Home » Topics » BioWorld Science

BioWorld Science
RSS

Combination therapy Maxamine/IL-2 effective in extending remission time & preventing relapse

Oct. 4, 1996

Progenics cancer vaccine enters clinical trials

Oct. 4, 1996

Novopharm develops new recombinant form of MAb

Oct. 4, 1996

Protein Design Labs' humanized antibody effective in reducing kidney transplant rejection

Oct. 4, 1996

First approval for a DTaP-IPV vaccine

Oct. 4, 1996

PPL Therapeutics-RPMS xenotransplantation collaboration

Oct. 4, 1996

delta-Opioid antagonists for non-CNS applications

Oct. 4, 1996

Pfizer halts U.S. development of tenidap for rheumatoid arthritis

Oct. 4, 1996

Fournier investigates deoxyspergualin analogues

Oct. 4, 1996

Enzyme inhibitor for autoimmune diseases isolated by Japanese researchers

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...